Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?

This publication has 11 references indexed in Scilit:

• A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
  AIDS, 1998
• A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients
  JAMA, 1998
• Visceral abdominal-fat accumulation associated with use of indinavir
  The Lancet, 1998
• “Buffalo hump” in men with HIV-1 infection
  The Lancet, 1998
• Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
  The Lancet, 1998
• Changes in AIDS incidence for men who have sex with men, United States 1990–1995
  AIDS, 1997
• A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease
  New England Journal of Medicine, 1995
• Asymptomatic Atherosclerosis in HIV-positive Patients: A Case-control Ultrasound Study
  Annals of Medicine, 1995
• Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis.
  Circulation, 1994
• Plasma lipids in HIV‐infected patients: a prospective study in 95 patients
  European Journal of Clinical Investigation, 1994